Sulfonamides Market, Global Outlook and Forecast 2022-2028

April 2022 | 63 pages | ID: S3C3F79B031EEN
Market Monitor Global

Abstracts

Sulfonamides (sulphonamides) is a man-made group of medicines that includes the sulfonamide chemical group. Which is also called sulfa drugs. Sulfonamide antimicrobials are bacteriostatic (helps to stop generating new bacteria, but don’t surely kill them) and also work by intervening with the fusion of folic acid in bacteria, which is important for the formation of nucleic acid and ultimately for DNA and RNA. Sulfonamides are generally used in the pharmaceutical industry at a high rate. Where it is used as bacteriostatic agents which helps to kill the bacteria from human as well as from the animal’s body. Sulfonamides can be prepared in many ways in the laboratory. Sulfonamides are generally used for diabetes, fluid retention, high blood pressure, crohn’s disease, etc.

This report contains market size and forecasts of Sulfonamides in Global, including the following market information:

Global Sulfonamides Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Sulfonamides market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Intestinal Absorption Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Sulfonamides include Pfizer, Sanofi, Roche, Mylan, Teva, Bayer, Abbott, GlaxoSmithKline and Boehringer Ingelheim. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Sulfonamides companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Sulfonamides Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Sulfonamides Market Segment Percentages, by Type, 2021 (%)

• Intestinal Absorption
• Intestinal Tract Difficult to Absorb
• External Use

Global Sulfonamides Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Sulfonamides Market Segment Percentages, by Application, 2021 (%)

• Systemic Infection
• Intestinal Infection
• Burn Infection
• Other Infections

Global Sulfonamides Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Sulfonamides Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Sulfonamides revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Sulfonamides revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer
• Sanofi
• Roche
• Mylan
• Teva
• Bayer
• Abbott
• GlaxoSmithKline
• Boehringer Ingelheim

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Sulfonamides Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Sulfonamides Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL SULFONAMIDES OVERALL MARKET SIZE

2.1 Global Sulfonamides Market Size: 2021 VS 2028
2.2 Global Sulfonamides Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Sulfonamides Players in Global Market
3.2 Top Global Sulfonamides Companies Ranked by Revenue
3.3 Global Sulfonamides Revenue by Companies
3.4 Top 3 and Top 5 Sulfonamides Companies in Global Market, by Revenue in 2021
3.5 Global Companies Sulfonamides Product Type
3.6 Tier 1, Tier 2 and Tier 3 Sulfonamides Players in Global Market
  3.6.1 List of Global Tier 1 Sulfonamides Companies
  3.6.2 List of Global Tier 2 and Tier 3 Sulfonamides Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Sulfonamides Market Size Markets, 2021 & 2028
  4.1.2 Intestinal Absorption
  4.1.3 Intestinal Tract Difficult to Absorb
  4.1.4 External Use
4.2 By Type - Global Sulfonamides Revenue & Forecasts
  4.2.1 By Type - Global Sulfonamides Revenue, 2017-2022
  4.2.2 By Type - Global Sulfonamides Revenue, 2023-2028
  4.2.3 By Type - Global Sulfonamides Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Sulfonamides Market Size, 2021 & 2028
  5.1.2 Systemic Infection
  5.1.3 Intestinal Infection
  5.1.4 Burn Infection
  5.1.5 Other Infections
5.2 By Application - Global Sulfonamides Revenue & Forecasts
  5.2.1 By Application - Global Sulfonamides Revenue, 2017-2022
  5.2.2 By Application - Global Sulfonamides Revenue, 2023-2028
  5.2.3 By Application - Global Sulfonamides Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Sulfonamides Market Size, 2021 & 2028
6.2 By Region - Global Sulfonamides Revenue & Forecasts
  6.2.1 By Region - Global Sulfonamides Revenue, 2017-2022
  6.2.2 By Region - Global Sulfonamides Revenue, 2023-2028
  6.2.3 By Region - Global Sulfonamides Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Sulfonamides Revenue, 2017-2028
  6.3.2 US Sulfonamides Market Size, 2017-2028
  6.3.3 Canada Sulfonamides Market Size, 2017-2028
  6.3.4 Mexico Sulfonamides Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Sulfonamides Revenue, 2017-2028
  6.4.2 Germany Sulfonamides Market Size, 2017-2028
  6.4.3 France Sulfonamides Market Size, 2017-2028
  6.4.4 U.K. Sulfonamides Market Size, 2017-2028
  6.4.5 Italy Sulfonamides Market Size, 2017-2028
  6.4.6 Russia Sulfonamides Market Size, 2017-2028
  6.4.7 Nordic Countries Sulfonamides Market Size, 2017-2028
  6.4.8 Benelux Sulfonamides Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Sulfonamides Revenue, 2017-2028
  6.5.2 China Sulfonamides Market Size, 2017-2028
  6.5.3 Japan Sulfonamides Market Size, 2017-2028
  6.5.4 South Korea Sulfonamides Market Size, 2017-2028
  6.5.5 Southeast Asia Sulfonamides Market Size, 2017-2028
  6.5.6 India Sulfonamides Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Sulfonamides Revenue, 2017-2028
  6.6.2 Brazil Sulfonamides Market Size, 2017-2028
  6.6.3 Argentina Sulfonamides Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Sulfonamides Revenue, 2017-2028
  6.7.2 Turkey Sulfonamides Market Size, 2017-2028
  6.7.3 Israel Sulfonamides Market Size, 2017-2028
  6.7.4 Saudi Arabia Sulfonamides Market Size, 2017-2028
  6.7.5 UAE Sulfonamides Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Pfizer
  7.1.1 Pfizer Corporate Summary
  7.1.2 Pfizer Business Overview
  7.1.3 Pfizer Sulfonamides Major Product Offerings
  7.1.4 Pfizer Sulfonamides Revenue in Global Market (2017-2022)
  7.1.5 Pfizer Key News
7.2 Sanofi
  7.2.1 Sanofi Corporate Summary
  7.2.2 Sanofi Business Overview
  7.2.3 Sanofi Sulfonamides Major Product Offerings
  7.2.4 Sanofi Sulfonamides Revenue in Global Market (2017-2022)
  7.2.5 Sanofi Key News
7.3 Roche
  7.3.1 Roche Corporate Summary
  7.3.2 Roche Business Overview
  7.3.3 Roche Sulfonamides Major Product Offerings
  7.3.4 Roche Sulfonamides Revenue in Global Market (2017-2022)
  7.3.5 Roche Key News
7.4 Mylan
  7.4.1 Mylan Corporate Summary
  7.4.2 Mylan Business Overview
  7.4.3 Mylan Sulfonamides Major Product Offerings
  7.4.4 Mylan Sulfonamides Revenue in Global Market (2017-2022)
  7.4.5 Mylan Key News
7.5 Teva
  7.5.1 Teva Corporate Summary
  7.5.2 Teva Business Overview
  7.5.3 Teva Sulfonamides Major Product Offerings
  7.5.4 Teva Sulfonamides Revenue in Global Market (2017-2022)
  7.5.5 Teva Key News
7.6 Bayer
  7.6.1 Bayer Corporate Summary
  7.6.2 Bayer Business Overview
  7.6.3 Bayer Sulfonamides Major Product Offerings
  7.6.4 Bayer Sulfonamides Revenue in Global Market (2017-2022)
  7.6.5 Bayer Key News
7.7 Abbott
  7.7.1 Abbott Corporate Summary
  7.7.2 Abbott Business Overview
  7.7.3 Abbott Sulfonamides Major Product Offerings
  7.7.4 Abbott Sulfonamides Revenue in Global Market (2017-2022)
  7.7.5 Abbott Key News
7.8 GlaxoSmithKline
  7.8.1 GlaxoSmithKline Corporate Summary
  7.8.2 GlaxoSmithKline Business Overview
  7.8.3 GlaxoSmithKline Sulfonamides Major Product Offerings
  7.8.4 GlaxoSmithKline Sulfonamides Revenue in Global Market (2017-2022)
  7.8.5 GlaxoSmithKline Key News
7.9 Boehringer Ingelheim
  7.9.1 Boehringer Ingelheim Corporate Summary
  7.9.2 Boehringer Ingelheim Business Overview
  7.9.3 Boehringer Ingelheim Sulfonamides Major Product Offerings
  7.9.4 Boehringer Ingelheim Sulfonamides Revenue in Global Market (2017-2022)
  7.9.5 Boehringer Ingelheim Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Sulfonamides Market Opportunities & Trends in Global Market
Table 2. Sulfonamides Market Drivers in Global Market
Table 3. Sulfonamides Market Restraints in Global Market
Table 4. Key Players of Sulfonamides in Global Market
Table 5. Top Sulfonamides Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Sulfonamides Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Sulfonamides Revenue Share by Companies, 2017-2022
Table 8. Global Companies Sulfonamides Product Type
Table 9. List of Global Tier 1 Sulfonamides Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Sulfonamides Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Sulfonamides Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Sulfonamides Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Sulfonamides Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Sulfonamides Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Sulfonamides Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Sulfonamides Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Sulfonamides Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Sulfonamides Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Sulfonamides Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Sulfonamides Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Sulfonamides Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Sulfonamides Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Sulfonamides Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Sulfonamides Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Sulfonamides Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Sulfonamides Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Sulfonamides Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Sulfonamides Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Sulfonamides Revenue, (US$, Mn), 2023-2028
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Sulfonamides Product Offerings
Table 32. Pfizer Sulfonamides Revenue (US$, Mn), (2017-2022)
Table 33. Sanofi Corporate Summary
Table 34. Sanofi Sulfonamides Product Offerings
Table 35. Sanofi Sulfonamides Revenue (US$, Mn), (2017-2022)
Table 36. Roche Corporate Summary
Table 37. Roche Sulfonamides Product Offerings
Table 38. Roche Sulfonamides Revenue (US$, Mn), (2017-2022)
Table 39. Mylan Corporate Summary
Table 40. Mylan Sulfonamides Product Offerings
Table 41. Mylan Sulfonamides Revenue (US$, Mn), (2017-2022)
Table 42. Teva Corporate Summary
Table 43. Teva Sulfonamides Product Offerings
Table 44. Teva Sulfonamides Revenue (US$, Mn), (2017-2022)
Table 45. Bayer Corporate Summary
Table 46. Bayer Sulfonamides Product Offerings
Table 47. Bayer Sulfonamides Revenue (US$, Mn), (2017-2022)
Table 48. Abbott Corporate Summary
Table 49. Abbott Sulfonamides Product Offerings
Table 50. Abbott Sulfonamides Revenue (US$, Mn), (2017-2022)
Table 51. GlaxoSmithKline Corporate Summary
Table 52. GlaxoSmithKline Sulfonamides Product Offerings
Table 53. GlaxoSmithKline Sulfonamides Revenue (US$, Mn), (2017-2022)
Table 54. Boehringer Ingelheim Corporate Summary
Table 55. Boehringer Ingelheim Sulfonamides Product Offerings
Table 56. Boehringer Ingelheim Sulfonamides Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Sulfonamides Segment by Type in 2021
Figure 2. Sulfonamides Segment by Application in 2021
Figure 3. Global Sulfonamides Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Sulfonamides Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Sulfonamides Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Sulfonamides Revenue in 2021
Figure 8. By Type - Global Sulfonamides Revenue Market Share, 2017-2028
Figure 9. By Application - Global Sulfonamides Revenue Market Share, 2017-2028
Figure 10. By Region - Global Sulfonamides Revenue Market Share, 2017-2028
Figure 11. By Country - North America Sulfonamides Revenue Market Share, 2017-2028
Figure 12. US Sulfonamides Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Sulfonamides Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Sulfonamides Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Sulfonamides Revenue Market Share, 2017-2028
Figure 16. Germany Sulfonamides Revenue, (US$, Mn), 2017-2028
Figure 17. France Sulfonamides Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Sulfonamides Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Sulfonamides Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Sulfonamides Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Sulfonamides Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Sulfonamides Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Sulfonamides Revenue Market Share, 2017-2028
Figure 24. China Sulfonamides Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Sulfonamides Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Sulfonamides Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Sulfonamides Revenue, (US$, Mn), 2017-2028
Figure 28. India Sulfonamides Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Sulfonamides Revenue Market Share, 2017-2028
Figure 30. Brazil Sulfonamides Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Sulfonamides Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Sulfonamides Revenue Market Share, 2017-2028
Figure 33. Turkey Sulfonamides Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Sulfonamides Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Sulfonamides Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Sulfonamides Revenue, (US$, Mn), 2017-2028
Figure 37. Pfizer Sulfonamides Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Sanofi Sulfonamides Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Roche Sulfonamides Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Mylan Sulfonamides Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Teva Sulfonamides Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Bayer Sulfonamides Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Abbott Sulfonamides Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. GlaxoSmithKline Sulfonamides Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Boehringer Ingelheim Sulfonamides Revenue Year Over Year Growth (US$, Mn) & (2017-2022)